A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults

Current Medical Research and Opinion

Volumn 22, Issue 2, 2006, Pages 275-285

  Emberlin, Jean C ^a   Lewis, R A ^b  

^a UNIVERSITY OF WORCESTER   (United Kingdom)

^b WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Hay fever; Inert cellulose powder; Seasonal allergic rhinitis

Indexed keywords

ANTIHISTAMINIC AGENT; CELLULOSE; EYE DROPS; HERBACEOUS AGENT; LACTOSE; NOSE SPRAY; PLACEBO; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRASS POLLEN; HAY FEVER; HOMEOPATHY; HUMAN; MALE; POWDER; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM; ADOLESCENT; ARTICLE; CHEMISTRY; DOUBLE BLIND PROCEDURE; MIDDLE AGED; POACEAE;

ADOLESCENT; ADULT; CELLULOSE; DOUBLE-BLIND METHOD; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PLACEBOS; POACEAE; POWDERS; RHINITIS, ALLERGIC, SEASONAL;

EID: 33645731785     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X80440     Document Type: Conference Paper

References (14)

1. Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8: 161-76
2. ISAAC Steering Committee. Worldwide variations in the prevalence of asthma symptoms. The International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998;12:315-53
3. Burr ML, Emberlin JC, Treu R, et al; ISAAC Phase One Study Group. Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 2003;33:1675-80
4. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis allergy. Allergy 1994;49(Suppl 9):5-34
5. Anderson HR, Ruggles R, Strachan DP, et al. Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12-14 year olds in the British Isles, 1995-2002: questionnaire survey. Br Med J 2004;328:1052-3
6. Emberlin J. Aerobiology In: Busse W, Holgate S, editors. Asthma and rhinitis, 2nd edn. Oxford: Blackwell Science; 2000. pp. 1083-107
7. Faegri K, Iverson J. A text book of pollen analysis. Denmark: John Wiley and Sons Ltd; 1989
8. Morrow Brown H, Jackson F. Aerobiological studies based in Derby, II. Simultaneous pollen and spore sampling at eight sites within a 60km radius. Clinical Allergy 1978;8:599-609
9. Jones S. Allergenic pollen concentrations in the United Kingdom. University of North London: PhD Thesis; 1995
10. British Aerobiology Federation. Airborne pollens and spores. A guide to trapping and counting [ISBN 0-9525617-0-0]. Harpenden: British Aerobiology Federation IACR; 1994
11. Rolinck-Werninghaus C, Hamelmann E, Keil T, et al. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy 2004;59(7):973-9
12. Miller M, Mehta K, Kunte S, et al. A randomized controlled trial [ISRCTN38432711]. Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination. J Inflamm 2005;2:11
13. Roefaro J, Daryanari AR. Treatment options for the management of chronic obstructive pulmonary disease. Formulary 2004;39:542-55
14. Davies RR, Smith LP. Forecasting the start and severity of the hay fever season. Clinical Allergy 1973;3:263-7